UK-based Tom Oliver Nutrition is employing Arctic Nutrition’s herring caviar Romega omega-3 in its omega-3 range for the first time.
Meanwhile fellow Norwegian supplier Omegatri has developed a hard tablet that will deliver 40–125 mg of omega-3 forms EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) per 1g tablet.
Tom Oliver Nutrition founder, Tom Oliver, said DHA-rich Romega was of the, “cutting edge of omega-3 phospholipids.”
Omegatri’s fish oil-based powder is formulated using “molecular stabilisation” to handle tableting. “This direct-compressible omega-3 powder is nearly an excipient in itself as it only needs a few percent of excipient in a tablet,” the company said.
The company said the hard tablet format offered shelf life benefits due to reduced oxidation issues compared to typical capsules.
Omegatri said the format offered blending potential with other nutrients like vitamins and minerals.
Arctic’s herring caviar derived, DHA-loaded omega-3 form was launched last year in
Europe and North America with Novastell coming onboard as the European distributor after the company exhibited at Vitafoods in Geneva and then Supply Side West in Las Vegas later in the year.
Manufactured in Arctic’s Norwegian GMP-certified facility and sourced from Marine Stewardship Council (MSC)-certified fisheries, the ingredient is priced at the premium end of the sector, between high-end fish oils and krill.